Two Emerging Growth Firms Surged +40% Today!
It was an amazing trading day for two emerging growth biotech stocks that respectively surged more than +40% into the close today on over a combined 45.5 million shares of trading volume! Who are they?
The first is Soligenix, Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Soligenix announced today that results from its ricin toxin vaccine (RiVax™) development program will be presented at the 20th Annual Conference on Vaccine Research, being held April 24-26 in Bethesda, Md.
“Serum Antibody Profiling following Vaccination Reveals a Correlate of Immunity to Ricin Toxin” will be presented by Jennifer Yates, Ph.D., New York State Department of Health, Wadsworth Center and attended by Oreola Donini, Ph.D., Chief Scientific Officer of Soligenix, on April 25 at 2:15 p.m. Eastern time.
RiVax™ is the Company’s proprietary vaccine candidate for the prevention of exposure to ricin toxin that utilizes a unique antigen that is completely devoid of the toxic activity of ricin. When formulated with ThermoVax®, Soligenix’s proprietary vaccine heat stabilization technology, RiVax™ has demonstrated significantly enhanced thermostability and 100% protection in preclinical ricin aerosol challenge models.
The second stock that surged was Cleveland BioLabs, Inc. ( NASDAQ : CBLI ) which recently announced that the U.S. Food and Drug Administration (FDA) has completed its review of a side-by-side analytical comparison of two formulations of entolimod. The FDA agreed with CBLI that these data indicate the in vitro analytical comparability of the formulations. Based on the outcome of its review, the FDA has provided CBLI with its consent for initiation of an in vivo biocomparability study of these formulations in non-human primates (NHP).
To gain a better understanding of emerging growth companies like Soligenix (SNGX) please visit the Coverage section of the Vista Partners website where you will find a company dedicated page for SNGX and other coverage pages on all components of the Dow30 and other interesting emerging growth companies.
We suggest you also take time to look at Digiliti Money (NASDAQ: DGLT) a fintech Firm that recently announced a partnership with MasterCard (NYSE: MA) , ICBA and Central Bank of Kansas City as we host a coverage page for them as well.